SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/20 Pentwater Capital Management LP SC 13G 1:51K Achillion Pharmaceuticals Inc Broadridge Fin’l So… Inc |
Document/Exhibit Description Pages Size 1: SC 13G Statement of Acquisition of Beneficial Ownership HTML 38K by a Passive Investor
Achillion Pharmaceuticals, Inc.
|
(Name of Issuer)
|
Common Stock, par value $0.001 per share
|
(Title of Class of Securities)
|
(CUSIP Number)
|
(Date of Event Which Requires Filing of this Statement)
|
* |
The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information
which would alter the disclosures provided in a prior cover page.
|
1
|
NAMES OF REPORTING PERSONS
|
|
|
||
Pentwater Capital Management LP
|
|
|
|||
|
|
||||
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
|
||||
(a)
|
☐ |
||||
(b)
|
☐ |
|
|||
3
|
SEC USE ONLY
|
|
|
||
|
|
|
|||
|
|
||||
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
|
|
|
||
Delaware USA
|
|
|
|||
|
|
||||
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5
|
SOLE VOTING POWER
|
|
|
|
7,511,700
|
|
|
|||
|
|
||||
6
|
SHARED VOTING POWER
|
|
|
||
|
|
|
|||
|
|
||||
7
|
SOLE DISPOSITIVE POWER
|
|
|
||
7,511,700
|
|
|
|||
|
|
||||
8
|
SHARED DISPOSITIVE POWER
|
|
|
||
|
|
|
|||
|
|
||||
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
|
|
|
||
7,511,700
|
|
|
|||
|
|
||||
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
|
|
|
||
☐ |
|
||||
|
|
||||
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
|
|
|
||
(1) 5.36%
|
|
|
|||
|
|
||||
12
|
TYPE OF REPORTING PERSON (SEE INSTRUCTIONS)
|
|
|
||
IA
|
|
|
|||
|
|
(1)
|
The percentage reported is based on 140,046,647 shares of Common Stock, par value $0.001 per share outstanding as of 11/1/19.
|
(a)
|
☐
|
Broker or dealer registered under Section 15 of the Exchange Act.
|
(b)
|
☐
|
Bank as defined in Section 3(a)(6) of the Exchange Act.
|
(c)
|
☐
|
Insurance company as defined in Section 3(a)(19) of the Exchange Act.
|
(d)
|
☐ |
Investment company registered under Section 8 of the Investment Company Act.
|
(e)
|
☑
|
An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
|
(f)
|
☐ |
An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
|
(g)
|
☐ |
A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);
|
(h)
|
☐ |
A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
|
(i)
|
☐ |
A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;
|
(j)
|
☐ |
Group, in accordance with
|
(Date)
|
|
(Signature)
|
|
Neal Nenadovic/Chief Financial Officer
|
|
(Name/Title)
|
This ‘SC 13G’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 2/14/20 | 13F-HR, SC 13G/A | ||
12/31/19 | 13F-HR | |||
List all Filings |